Arizona Cancer Center Biospecimen Repository

University of Arizona

Status: Enrolling

Conditions: Cancer

Treatments: Other: biologic sample preservation procedure

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT00896935

UARIZ-SRC18042 (Other Identifier)

P30CA023074 (U.S. NIH Grant/Contract)

UARIZ-BIO#A06035 (Other Identifier)

CDR0000597579

UARIZ-06-0609-04 (Other Identifier)

Details and patient eligibility

About

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Full description

OBJECTIVES:

• Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer.
• Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine.
• Provide quality-controlled storage and management of the specimen bank.
• Collect relevant clinical and pathologic information with appropriate privacy protection.
• Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

• Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

• NA

PRIOR CONCURRENT THERAPY:

• NA

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.